Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment.

J Immunother Cancer · 2019 · PMC6740011 · PMID 31511069

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In contrast, the majority of antigen-specific T cells detected in non-responders showed a trend toward a higher expression of CD127, CD28, CD27, and CCR7 (Fig. 3 b).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.